Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 43, Issue 20, Page 15 (15 October 2008)


View previous. 14 of 27 View next.

Philadelphia Story: 93% Finish HIV Vaccine Trial

SUSAN LONDON (Contributing Writer)

MEXICO CITY — Retention strategies helped ensure that about 93% of high-risk, drug-using women in Philadelphia participating in the HIV vaccine trial completed the trial and 90% received all vaccinations.

PII: S0029-7437(08)70644-X

doi:10.1016/S0029-7437(08)70644-X


View previous. 14 of 27 View next.